Direct PeptidesProduct page includes use or preparation wordingIn stock
Semax · 10 mg × 10 vials
$349.00$3.49 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship
Research listings · Peptides
Semax research listings: prices and suppliers
Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.
We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.
Prices observed weekly · last check · How we check prices →
Lowest current at 10 mg × 10 vials$3.49 / mg · $349.00Direct Peptides · checked 5 days ago
Listings at 10 mg × 10 vials
| Supplier link | |||||||
|---|---|---|---|---|---|---|---|
| Direct PeptidesProduct page includes use or preparation wording | 10 mg × 10 vials | $349.00 | $3.49 / mg | In stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
- Prices exclude shipping. A matching name does not verify the contents of a lot.
- Lab reports are vendor-reported, not independently authenticated. “Lab confirmed” means the issuing laboratory confirmed the report is theirs.
- Some suppliers’ product pages include use or preparation wording. We list their prices for comparison only; we do not endorse that wording, and nothing on this site is guidance on preparing or using these materials.
By size
Every package size we track for Semax. Current means seen in the last 8 days.
| 5 mg × 1 vial | $50.00 | $10.00 / mg | 1 / 1 | 0 |
|---|---|---|---|---|
| 10 mg × 1 vial | $34.99 | $3.50 / mg | 8 / 9 | 8 |
| 25 mg × 1 vial | $53.00 | $2.12 / mg | 2 / 2 | 2 |
| 30 mg × 1 vial | — | — | 0 / 1 | 0 |
| 10 mg × 10 vials | $349.00 | $3.49 / mg | 1 / 1 | 1 |
Research context
From our own records, with the date each was last checked.
- FDA approval
- No approved drug product with this ingredient listed in Drugs@FDA (data updated 2026-11-02)Checked
- 503A / 503B compounding
- Named in a draft HHS enforcement-discretion policy (2026-10-30) covering semax free base for intranasal use until rulemaking; not an approval or a 503A listing. Formerly category 2, withdrawnChecked
- Advisory committee (PCAC)
- PCAC discussed semax and semax acetate on 2026-07-24 (uses reviewed: cerebral ischemia, migraine, trigeminal neuralgia); FDA's briefing weighed against listingChecked
- Rulemaking / enforcement
- HHS notice of a draft peptide enforcement-discretion policy published 2026-10-30 (comments for 2 weeks); no proposed or final 503A rule on semax found (search on 2026-11-03)Checked
- Identity
- Formula C37H51N9O10S · MW 813.9 g/mol · CAS 80714-61-0Sequence MEHFPGPSource record Checked
Identity noteN-acetyl semax amidate (NA-semax amidate) is a different molecule and is tracked as a separate substance.
How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.